http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IN-2014MN01555-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c6107abcc76ad54b3821249d6315e0ab
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T428-1397
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B65D65-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-121
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L12-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N1-0226
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-121
filingDate 2013-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f93e8acb4a2d6b8f425770cd8129b91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6443ea868095bea6e5c4951b5a7a963f
publicationDate 2015-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber IN-2014MN01555-A
abstract An ophthalmic composition kit in which an ophthalmic composition containing a geranylgeranylacetone is stored in an ophthalmic container wherein at least a portion of or the entire surface of the ophthalmic container that comes into contact with the ophthalmic composition is configured from a container material selected from among a polyolefin an acrylic acid resin a terephthalic acid ester a polycarbonate a polymethyl terpene a fluorine resin or glass. In said ophthalmic composition kit the decline in the content or concentration of the geranylgeranylacetone within the ophthalmic composition is extremely small.
priorityDate 2012-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559562
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6581
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410422147
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53384398
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474364

Total number of triples: 30.